2020
DOI: 10.1093/pm/pnaa054
|View full text |Cite
|
Sign up to set email alerts
|

Co-prescribing of Opioids with Benzodiazepines and Other Hypnotics for Chronic Pain and Insomnia: Trends and Health Outcomes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
5
0
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 29 publications
1
5
0
2
Order By: Relevance
“…Recently, a narrative review has suggested that BZRAs have analgesic benefits for burning mouth syndrome and stiff person syndrome and for treating co-occurring insomnia and anxiety disorders for short periods of time (2–4 weeks) in CP management ( 71 ). Special attention should be required because co-prescribing of BZRAs with opioids for CP and insomnia is common in clinical practice ( 72 ). In 2016, the U.S. Food and Drug Administration (FDA) issued a strong official strong warning for the co-usage of opioids and benzodiazepines due to an increased risk of overdose deaths.…”
Section: Clinical Research On the Relationship Between Chronic Pain A...mentioning
confidence: 99%
“…Recently, a narrative review has suggested that BZRAs have analgesic benefits for burning mouth syndrome and stiff person syndrome and for treating co-occurring insomnia and anxiety disorders for short periods of time (2–4 weeks) in CP management ( 71 ). Special attention should be required because co-prescribing of BZRAs with opioids for CP and insomnia is common in clinical practice ( 72 ). In 2016, the U.S. Food and Drug Administration (FDA) issued a strong official strong warning for the co-usage of opioids and benzodiazepines due to an increased risk of overdose deaths.…”
Section: Clinical Research On the Relationship Between Chronic Pain A...mentioning
confidence: 99%
“…A prescrição para o tratamento de insônia de benzodiazepínicos devem ser opções para casos agudos, novas pesquisas dos medicamentos pertencentes ao grupo são necessárias, fundamentalmente sobre o uso racional e seguro 1,18 . Em casos crônicos deve preferencialmente utilizar a combinação de terapias comportamentais e se necessário medicações escalonadas 18 , pode ser empregado terapêuticas complementares e alternativas 19 , como fitoterápicos, homeopáticos, terapia cognitivo-comportamental para insônia (TCC-I) 20,22,23 , evitando a prescrição de substâncias controladas 21 e realizando a descontinuação em casos de uso crônico 24,25,26,27,28 . O diagnóstico de insônia crônica é caso atenda os seguintes critérios: ocorrência dos sintomas no mínimo 3 vezes na semana e com duração acima de 3 meses 29 .…”
Section: Conclusãounclassified
“…Moreover, opioid use was shown to acutely disrupt sleep-regulatory systems in the brain, affecting the time it takes to fall asleep (latency), duration of sleep, and sleep quality 85 . Increased side effects can occur if opioids are combined with insomnia medications such as benzodiazepines, hypnotics, or gabapentinoids [86][87][88] , especially among the elderly. Moreover, there is growing evidence suggesting that poor sleep could increase opioid craving levels and opioid misuse in different populations, including patients with chronic pain who are prescribed opioids [89][90][91] , suggesting a bidirectional relationship between opioids and disrupted sleep 85,92 .…”
Section: Important Management Considerationsmentioning
confidence: 99%